Neonatal Stand-Alone Screening Kit For Metabolic Disorders Cleared By FDA
This article was originally published in The Gray Sheet
Executive Summary
PerkinElmer will market its NeoGram amino acids and acylcarnitines tandem mass spectrometry (TMS) kit as a cost-effective alternative to laboratory blood testing for individual defects of metabolism among newborns
You may also be interested in...
National Newborn Screening Program Could Benefit States, Be Cost-Effective
A nationally-mandated newborn screening program for 29 heritable diseases could benefit individual states, according to an FDL-1HHS advisory panel report released March 8 in the Federal Register
National Newborn Screening Program Could Benefit States, Be Cost-Effective
A nationally-mandated newborn screening program for 29 heritable diseases could benefit individual states, according to an FDL-1HHS advisory panel report released March 8 in the Federal Register
HHS Heritable Disease Panel To Recommend Core Newborn Screening Menu
Recommendations on the minimum requirements that states should set for newborn screening of heritable disorders will be formalized at a Health Resources & Services Administration meeting Sept. 22-23